Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.72K Hold
346
﹤0.01% 294
2025
Q4
$8.62K Hold
346
﹤0.01% 306
2025
Q3
$8.82K Buy
346
+66
+24% +$1.63K ﹤0.01% 302
2025
Q2
$6.79K Sell
280
-264
-49% -$6.16K ﹤0.01% 322
2025
Q1
$13.8K Buy
+544
New +$14.2K 0.01% 193
2024
Q4
Sell
-537
Closed -$15.5K 605
2024
Q3
$15.5K Hold
537
0.01% 188
2024
Q2
$15K Buy
537
+176
+49% +$4.85K 0.01% 186
2024
Q1
$10K Sell
361
-232
-39% -$6.44K 0.01% 225
2023
Q4
$17.1K Buy
593
+435
+275% +$13.2K 0.01% 142
2023
Q3
$5.24K Sell
158
-568
-78% -$20.1K ﹤0.01% 273
2023
Q2
$26.6K Buy
726
+243
+50% +$9.46K 0.02% 117
2023
Q1
$19.7K Sell
483
-594
-55% -$25.7K 0.01% 138
2022
Q4
$55.2K Buy
+1,077
New +$51.6K 0.04% 113
2021
Q4
Sell
-558
Closed -$24K 390
2021
Q3
$24K Buy
+558
New +$24.7K 0.02% 152

Other funds holding PFE

Red Tortoise LLC's PFE Position: Q1 2026 in Review

Red Tortoise LLC held its Pfizer (PFE) position steady in Q1 2026 at 346 shares worth $9.72K. The position accounts for ﹤0.01% of the portfolio, ranked #294.

Red Tortoise LLC first reported a position in PFE in Q3 2021 and has held it in 14 quarters since. The position peaked at $55.2K in Q4 2022. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Red Tortoise LLC held 346 shares of Pfizer worth $9.72K as of Q1 2026.
  • Red Tortoise LLC left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up ﹤0.01% of Red Tortoise LLC's portfolio in Q1 2026, its #294 holding.
  • Red Tortoise LLC first reported a position in Pfizer in Q3 2021 and has held it in 14 quarters since.
  • Red Tortoise LLC's Pfizer position peaked at $55.2K in Q4 2022.
  • 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Red Tortoise LLC's 13F filing for Q1 2026, filed 21 Apr 2026.